Catalyst Wire Dossier Catalyst Wire Dossier

Fortelyzin

staphylokinase, recombinant, nonimmunogenic
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fortelyzin, covering 2025-04-02 to 2025-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Single Bolus Recombinant Nonimmunogenic Staphylokinase (Fortelyzin) and Bolus Infusion Alteplase in Patients With AIS [Phase 3]

See pricing